ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Drugs associated with increased risk of adverse effects in patients with heart failure

Drugs associated with increased risk of adverse effects in patients with heart failure
Drug/drug class Adverse effect(s)
Anti-inflammatory medications
Glucocorticoids Sodium retention (particularly with fludrocortisone, hydrocortisone)
NSAIDs Sodium retention and peripheral vasocontriction; blunted response to diuretics and angiotensin converting enzyme inhibitors
Cardiovascular medications
Class I antiarrhythmic agents* Negative inotropy; proarrhythmia; increased mortality with IA and IC agents in post-MI trials
Class III antiarrhythmic agents (included sotalol and ibutalide)* Proarrhythmia
Calcium channel blockers (other than amlodipine or felodipine)* Negative inotropy; neurohumoral activation
Minoxidil* Sodium retention; neurohumoral activation
Diabetes medications
Metformin Lactic acidosis
Thiazolidinediones Sodium retention
Phosphdiesterase inhibitors
Anagrelide Palpitations; tachycardia; sodium retention; induction or exacerbation of HF
Cilostazol Ventricular tachyarrhythmias
Neurologic and psychiatric medications
Amphetamines* Sympathetic agonist activity; hypertension; tachycardia; tachyarrhythmias
Carbamazepine Negative inotropic effect; bradyarrhythmias
Clozapine Development of myocarditis and cardiomyopathy
Ergot alkaloids (ergotamine, dihydroergotamine) Sympathetic agonist activity; valve fibrosis
Pergolide (not available in the US) Valve fibrosis
Tricyclic antidepressants Negative inotropic effect; proarrhythmia
Miscellaneous
Beta-2 agonists Sympathetic agonist activity; tachyarrhythmias; hypokalemia
Trimethoprim-sulfamethoxazole Risk of hyperkalemia or acute kidney injury when taken with ACE inhibitor or ARB
Risk of hyperkalemia when taken with MRA
Itraconazole Negative inotropic effect; also can increase serum digoxin concentrations
Licorice Mineralocorticoid excess: sodium retention and hypokalemia
Sodium-containing preparations (eg, Fleet PhosPho soda)  
Sodium load QT-prolonging drugs (eg, haloperidol, erythromycin) Proarrhythmia
NSAIDs: nonsteroidal anti-inflammatory drugs; MI: myocardial infarction; HF: heart failure; ACE: angiotensin-converting enzyme; ARB: angiotension II receptor blockers; MRA: mineralocorticoid receptor antagonist.
* Evidence from randomized placebo controlled trials.
¶ Increased risk noted in American College of Cardiology/American Heart Association heart failure guidelines (Hunt SA, et al. Circulation 2005; 112:e154.).
Data modified from Amabile CM, Spencer AP. Arch Intern Med 2004; 164:709.
Graphic 68838 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟